Phase 2 N=17 Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy
HIV Infection
Primary: Occurrence of Grade ≥ 1 Adverse Events (AEs) — 5; 26; 4 events
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=256 A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia
Schizophrenia
Primary: Change From Baseline on the PANSS NSFS at Week 12 — -3.1; -3.3; -3.4; -2.5 scores on a scale — p=0.426
N/A N=90 Clinical Performance of Masimo INVSENSOR00040
Healthy
Primary: Oxygen Saturation (SpO2) Accuracy of INVSENSOR00040 — 1.62 % of oxygen saturated hemoglobin
N/A N=10 Immersive Virtual Reality in Stroke Pilot Study
Stroke
Primary: Action Research Arm Test — 38.80 Units on a Scale
N/A N=153 Exercise Program in Cancer and Cognition
Breast Cancer
Primary: Change in Cognitive Function — -0.05; 0.01; 0.21; 0.17 z-score
Phase 4 N=47 Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose
Type 1 Diabetes
Primary: Mean Change in Percent Time in Range — 2; -6.1 percentage of time in measured period — p=0.14
N/A N=43 Adherence to HIV Treatment Postpartum: The Implications of Transitions Among Women Living With HIV in South Africa
HIV · Pregnancy Related
Primary: Feasibility of the Intervention - Number of Counseling Sessions — 2.92; 1 sessions
N/A N=12 Implant-fixed Restorations With ANKYLOS 6.6 mm Implants in the Edentulous Maxilla - A 5-year Follow-up Study
Edentulous Maxilla
Primary: Implant Survival Rate — 41; 19 Implants
Phase 2 N=7 IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency
Short Stature
Primary: Height Velocity — 3.0; 4.3; 6.2; 4.8 cm/y
N/A N=6 Esophageal Cooling in Radiofrequency Cardiac Ablation
Atrial Fibrillation
Primary: Esophageal Mucosal Damage — 1; 1.33333 score on a scale
Phase 2 N=73 Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
FLT3 Gene Mutation Negative · FLT3 Internal Tandem Duplication Positive · Recurrent Acute Myeloid Leukemia
Primary: Maximum Tolerated Dose of Quizartinib (Phase I) — 60; 60 Milligrams
Phase 2 N=31 A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia
Schizophrenia
Primary: Change From Baseline in Average Percent of Conditioned Responses During the Eye Blink Conditioning (EBC) Test at Day 8 — 0.597; 0.319; 0.578; 1.344 Percent of…
N/A N=37 Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 Diabetes
Type 1 Diabetes
Primary: IDAA1c — 5; 2 Participants
N/A N=601 Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer
Advanced Malignant Neoplasm · Locally Advanced Malignant Neoplasm
Primary: Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education — 1.43; -0.80 score on a scale — p=<.0001
Phase 1 N=96 A Study of Soticlestat Tablets in Healthy Adults
Healthy Volunteers
Primary: Cmax: Maximum Observed Plasma Concentration for Soticlestat — 1762; 1428; 1708; 1509 nanogram per milllilitre (ng/ml)